Clinical trials: Nulligravid
Postpartum, Muscle Fatigue
Muscle Function After Childbirth
This study will evaluate lower extremity and trunk neuromuscular control in 78 nulligravid and postpartum women. Participants will attend two experimental sessions, approximately 1 week apart, to assess neuromuscular function.
- Conditions
- Postpartum, Muscle Fatigue, Force Steadiness, Nulligravid
- Trial name
- NCT05073224
- Testing
- Active Straight Leg Raise Test, Active Straight Leg Raise Fatigue Task, Lower Extremity Strength Testing
- Where
- United States
- Volunteers
- 78 people, healthy volunteers welcome
- Sponsor
- Carroll University
Malaria, Antepartum
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted
Despite having developed robust acquired immunity against complications of malaria, women can return to a susceptible state during their first pregnancies and contribute significantly to the burden of severe malaria in highly…
- Trial name
- PAMVAC (NCT02647489)
- Testing
- PAMVAC, Alhydrogel, GLA-SE
- Where
- Benin
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- University Hospital Tuebingen
Stress Urinary Incontinence
Prevalence of Stress Urinary Incontinence in Obese Versus Non-obese Nulligravid Women
Urinary incontinence (UI) is more common than any other chronic disease. Stress urinary incontinence (SUI), among the various forms of urinary incontinence, is the most prevalent (50%) type of this condition.
- Trial name
- NCT05845320
- Testing
- ICIQ-UI SF questionnaire
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Ain Shams University
Malaria in Pregnancy
Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine
Study Population: Participants of the previous PRIMVAC vaccine trial and women aged 18 to 35 years Sample Size: 90 Study duration: 21 months Subject duration: 12 months if pregnancy doesn't occurred.
- Trial name
- PRIMVACLongT (NCT05426187)
- Where
- Burkina Faso
- Volunteers
- 90 people
- Sponsor
- Groupe de Recherche Action en Sante